Tuberculosis
13 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Bacillus calmette-guerin live antigen, unspecified substrain for tuberculosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Bedaquiline for tuberculosis, multidrug-resistant | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Blmz for tuberculosis, multidrug-resistant | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| BPaLMZ Regimen for latent tuberculosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Dolutegravir + Isoniazid + RIFAPENTINE for latent tuberculosis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Isoniazid + RIFAPENTINE for latent tuberculosis | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine for tuberculosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Metformin for tuberculosis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Moxifloxacin + rifapentine for tuberculosis, lymph node | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Mtbvac for tuberculosis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| N-Acetylcysteine (NAC) Treatment for tuberculosis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Placebo for tuberculosis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Quabodepistat for tuberculosis, multidrug-resistant | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |